The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy.
The discussion of adequate compliance in health care often refers to a lack of information between patients and physicians. In our setting, we show that contract arrangements as well as the distribution of information are important for an adequate alignment of the interest of patients and physicians. The analysis emphasises the benefit of organised pharmaco-therapy enhancing the concomitant compliance. Therefore, the results can work as a proxy for the need of good economic-based approaches discussing compliance in chronic diseases.
Oberender
Peter
P
Research Institute for Social Law and Health Economics, University of Bayreuth, 95440, Bayreuth, Germany. peter.oberender@uni-bayreuth.de
Zerth
Jürgen
J
D050071:Bone Density Conservation Agents / Q000191:economics* / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000191:economics* / Q000627:therapeutic use; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D019587:Dietary Supplements / Q000191:economics; D004164:Diphosphonates / Q000191:economics* / Q000627:therapeutic use; D004338:Drug Combinations; D004349:Drug Packaging; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D017059:Models, Econometric; D010024:Osteoporosis / Q000178:diet therapy / Q000188:drug therapy / Q000191:economics / Q000523:psychology; D010349:Patient Compliance; D010817:Physician-Patient Relations; D020849:Raloxifene Hydrochloride / Q000191:economics* / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D004338:Drug Combinations; D020849:Raloxifene Hydrochloride